GRI Bio, Inc.
GRI · NASDAQ
7/31/2025 | 4/30/2025 | 1/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $0 | $23 | – | $0 |
| % Growth | -100% | – | – | – |
| Cost of Goods Sold | $0 | $0 | – | $0 |
| Gross Profit | -$0 | $11 | – | -$0 |
| % Margin | – | 48.4% | – | – |
| R&D Expenses | $2 | $2 | – | $1 |
| G&A Expenses | $1 | $1 | – | $1 |
| SG&A Expenses | $1 | $1 | – | $1 |
| Sales & Mktg Exp. | $0 | $0 | – | $0 |
| Other Operating Expenses | $0 | $0 | – | $0 |
| Operating Expenses | $3 | $3 | – | $2 |
| Operating Income | -$3 | -$3 | – | -$2 |
| % Margin | – | -13.5% | – | – |
| Other Income/Exp. Net | $0 | $0 | – | $0 |
| Pre-Tax Income | -$3 | -$3 | – | -$2 |
| Tax Expense | $0 | $0 | – | $0 |
| Net Income | -$3 | -$3 | – | -$2 |
| % Margin | – | -13.5% | – | – |
| EPS | -1.31 | -5.8 | – | -7.86 |
| % Growth | 77.4% | – | – | – |
| EPS Diluted | -1.31 | -5.8 | – | -7.86 |
| Weighted Avg Shares Out | 2 | 1 | – | 0 |
| Weighted Avg Shares Out Dil | 2 | 1 | – | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | – | $0 |
| Interest Expense | $0 | $0 | – | $0 |
| Depreciation & Amortization | $0 | $0 | – | $0 |
| EBITDA | -$3 | -$3 | – | -$2 |
| % Margin | – | -13.5% | – | – |